Dana J Holger (Dana Holger)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Topics

Combination Therapy

Pseudomonas Aeruginosa

Acinetobacter Baumannii

Top Venues

Pharmacotherapy

Open forum infectious diseases

Antimicrobial agents and chemotherapy

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy 44 (3) (2024)
Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy (2024)
Dana J Holger, Ali Althubyani, Taylor Morrisette, Nicholas Rebold, Marylee Tailor
Updates in pulmonary drug-resistant tuberculosis pharmacotherapy: A focus on BPaL and BPaLM. Pharmacotherapy 44 (3) (2024)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Dana J Holger, Amer El Ghali, Natasha Bhutani, Katherine L Lev, Kyle Stamper, Razieh Kebriaei, Ashlan J Kunz Coyne, Taylor Morrisette, Rahi Shah, Jose Alexander, Susan M Lehman, Laura J Rojas, Steven H Marshall, Robert A Bonomo, Michael Joseph Rybak
Phage-antibiotic combinations against multidrug-resistant Pseudomonas aeruginosa in in vitro static and dynamic biofilm models. Antimicrobial agents and chemotherapy (2023)
Ashlan J Kunz Coyne, Amer El Ghali, Kristen Lucas, Paige Witucki, Nicholas Rebold, Dana J Holger, Michael P Veve, Michael Joseph Rybak
High-dose Cefepime vs Carbapenems for Bacteremia Caused by Enterobacterales With Moderate to High Risk of Clinically Significant AmpC β-lactamase Production. Open forum infectious diseases 10 (3) (2023)
Amer El Ghali, Kyle Stamper, Ashlan J Kunz Coyne, Dana J Holger, Razieh Kebriaei, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Ciprofloxacin in combination with bacteriophage cocktails against multi-drug resistant Pseudomonas aeruginosa in ex vivo simulated endocardial vegetation models. Antimicrobial agents and chemotherapy (2023)
Razieh Kebriaei, Katherine L Lev, Rahi M Shah, Kyle C Stamper, Dana J Holger, Michael J Rybak, Ashlan J Kunz Coyne, Susan M Lehman, Michael Joseph Rybak
Eradication of Biofilm-Mediated Methicillin-Resistant Staphylococcus aureus Infections In Vitro : Bacteriophage-Antibiotic Combination. Microbiology spectrum 10 (2) (2022)
Dana J Holger, Katherine L Lev, Razieh Kebriaei, Taylor Morrisette, Rahi Shah, Jose Alexander, Susan M Lehman, Michael Joseph Rybak
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testing. Journal of applied microbiology 133 (3) (2022)
Ashlan J Kunz Coyne, Amer El Ghali, Dana J Holger, Nicholas Rebold, Michael J Rybak
Therapeutic Strategies for Emerging Multidrug-Resistant Pseudomonas aeruginosa. Infectious diseases and therapy 11 (2) (2022)
Ashlan J Kunz Coyne, Kyle Stamper, Razieh Kebriaei, Dana J Holger, Amer El Ghali, Taylor Morrisette, Biswajit Biswas, Melanie Wilson, Michael V Deschenes, Gregory S Canfield, Breck A Duerkop, Cesar A Arias, Michael Joseph Rybak
Phage Cocktails with Daptomycin and Ampicillin Eradicates Biofilm-Embedded Multidrug-Resistant Enterococcus faecium with Preserved Phage Susceptibility. Antibiotics (Basel, Switzerland) 11 (9) (2022)